ANGLE plc  

(Public, LON:AGL)   Watch this stock  
Find more results for Andrew Angle´┐Ż
-0.60 (-0.77%)
Real-time:   9:20AM GMT
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 77.00 - 77.40
52 week 53.70 - 107.83
Open 78.00
Vol / Avg. 31,053.00/105,286.00
Mkt cap 45.65M*
P/E     -
Div/yield     -
EPS -0.08*
Shares 58.98M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Apr '15) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -56.28% -44.52%
Return on average equity -54.32% -42.64%
Employees 29 -
CDP Score - -


The Surrey Research Park 3 Frederick Sanger Road
United Kingdom - Map
+44-1483-685830 (Phone)
+44-1483-685836 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


ANGLE plc is a United Kingdom-based holding company. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its lead product is Parsortix cell separation system, which can capture circulating tumor cells (CTCs) in cancer patient blood even when there is less than one CTC in one billion healthy cells. The resulting liquid biopsy enables the investigation of mutations in the patient's cancer for personalized cancer care. The Parsortix GEN3 Cassette is able to capture circulating tumor cells in cancer patient blood and works with a variety of cancers, including ovarian, prostate, breast, lung, colorectal, pancreatic and renal. The Company manages any overseas research, development (R&D), sales, and marketing from the United Kingdom segment. The Company's subsidiaries include ANGLE Europe Limited, ANGLE North America Inc, ANGLE Technology Limited, ANGLE Partnerships Limited and ANGLE Technology Licensing Limited.

Officers and directors

Andrew D. W. Newland Chief Executive, Executive Director
Ian F. Griffiths Finance Director, Company Secretary, Executive Director
Garth R. Selvey Non-Executive Chairman of the Board
Age: 59
Brian Howlett Non-Executive Director
David W. Quysner CBE Non-Executive Independent Director